EMEA (Europe, Middle East and Africa) Human Rotavirus Vaccine Market Report 2017

January 2018 | 109 pages | ID: EC5EA584921EN
QYResearch

Abstracts

In this report, the EMEA Human Rotavirus Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Human Rotavirus Vaccine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Rotavirus Vaccine market competition by top manufacturers/players, with Human Rotavirus Vaccine sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck & Co., Inc.
• Bharat Biotech
• GlaxoSmithKline plc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Rotarix
• RotaTeq
• Rotavac
• Rotavin-M1
• Lanzhou lamb

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Clinics
• Academic and Research
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Human Rotavirus Vaccine Market Report 2017

1 HUMAN ROTAVIRUS VACCINE OVERVIEW

1.1 Product Overview and Scope of Human Rotavirus Vaccine
1.2 Classification of Human Rotavirus Vaccine
  1.2.1 EMEA Human Rotavirus Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Human Rotavirus Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Rotarix
  1.2.4 RotaTeq
  1.2.5 Rotavac
  1.2.6 Rotavin-M1
  1.2.7 Lanzhou lamb
1.3 EMEA Human Rotavirus Vaccine Market by Application/End Users
  1.3.1 EMEA Human Rotavirus Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Academic and Research
  1.3.5 Others
1.4 EMEA Human Rotavirus Vaccine Market by Region
  1.4.1 EMEA Human Rotavirus Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Human Rotavirus Vaccine (2012-2022)
  1.5.1 EMEA Human Rotavirus Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Human Rotavirus Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA HUMAN ROTAVIRUS VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Human Rotavirus Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA Human Rotavirus Vaccine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Human Rotavirus Vaccine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Human Rotavirus Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Human Rotavirus Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Human Rotavirus Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Human Rotavirus Vaccine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Human Rotavirus Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Human Rotavirus Vaccine (Volume) by Application
2.4 EMEA Human Rotavirus Vaccine (Volume and Value) by Region
  2.4.1 EMEA Human Rotavirus Vaccine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Human Rotavirus Vaccine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Human Rotavirus Vaccine Sales Price by Region (2012-2017)

3 EUROPE HUMAN ROTAVIRUS VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Human Rotavirus Vaccine Sales and Value (2012-2017)
  3.1.1 Europe Human Rotavirus Vaccine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Human Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Human Rotavirus Vaccine Sales and Market Share by Type
3.3 Europe Human Rotavirus Vaccine Sales and Market Share by Application
3.4 Europe Human Rotavirus Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Human Rotavirus Vaccine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Human Rotavirus Vaccine Revenue by Countries (2012-2017)
  3.4.3 Germany Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  3.4.4 France Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  3.4.5 UK Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST HUMAN ROTAVIRUS VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Human Rotavirus Vaccine Sales and Value (2012-2017)
  4.1.1 Middle East Human Rotavirus Vaccine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Human Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Human Rotavirus Vaccine Sales and Market Share by Type
4.3 Middle East Human Rotavirus Vaccine Sales and Market Share by Application
4.4 Middle East Human Rotavirus Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Human Rotavirus Vaccine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Human Rotavirus Vaccine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)

5 AFRICA HUMAN ROTAVIRUS VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Human Rotavirus Vaccine Sales and Value (2012-2017)
  5.1.1 Africa Human Rotavirus Vaccine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Human Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Human Rotavirus Vaccine Sales and Market Share by Type
5.3 Africa Human Rotavirus Vaccine Sales and Market Share by Application
5.4 Africa Human Rotavirus Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Human Rotavirus Vaccine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Human Rotavirus Vaccine Revenue by Countries (2012-2017)
  5.4.3 South Africa Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Human Rotavirus Vaccine Sales and Growth Rate (2012-2017)

6 EMEA HUMAN ROTAVIRUS VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Merck & Co., Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Rotavirus Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck & Co., Inc. Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bharat Biotech
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Human Rotavirus Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bharat Biotech Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline plc.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Human Rotavirus Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline plc. Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview

7 HUMAN ROTAVIRUS VACCINE MANUFACTURING COST ANALYSIS

7.1 Human Rotavirus Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Rotavirus Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Rotavirus Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Rotavirus Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HUMAN ROTAVIRUS VACCINE MARKET FORECAST (2017-2022)

11.1 EMEA Human Rotavirus Vaccine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Human Rotavirus Vaccine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Human Rotavirus Vaccine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Human Rotavirus Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Human Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Human Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Human Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Human Rotavirus Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Human Rotavirus Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Human Rotavirus Vaccine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Rotavirus Vaccine
Figure EMEA Human Rotavirus Vaccine Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Human Rotavirus Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Rotarix Product Picture
Figure RotaTeq Product Picture
Figure Rotavac Product Picture
Figure Rotavin-M1 Product Picture
Figure Lanzhou lamb Product Picture
Figure EMEA Human Rotavirus Vaccine Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Human Rotavirus Vaccine by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Academic and Research Examples
Table Key Downstream Customer in Academic and Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Human Rotavirus Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Human Rotavirus Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Human Rotavirus Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Human Rotavirus Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Human Rotavirus Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Human Rotavirus Vaccine Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Human Rotavirus Vaccine Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Human Rotavirus Vaccine Sales Share by Players (2012-2017)
Figure 2016 Human Rotavirus Vaccine Sales Share by Players
Figure 2017 Human Rotavirus Vaccine Sales Share by Players
Figure EMEA Human Rotavirus Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Human Rotavirus Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Human Rotavirus Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Human Rotavirus Vaccine Revenue Share by Players
Table 2017 EMEA Human Rotavirus Vaccine Revenue Share by Players
Table EMEA Human Rotavirus Vaccine Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Human Rotavirus Vaccine Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Human Rotavirus Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Human Rotavirus Vaccine by Type (2012-2017)
Figure EMEA Human Rotavirus Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Human Rotavirus Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Human Rotavirus Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Rotavirus Vaccine by Type in 2016
Table EMEA Human Rotavirus Vaccine Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Human Rotavirus Vaccine Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Human Rotavirus Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Human Rotavirus Vaccine by Application (2012-2017)
Figure EMEA Human Rotavirus Vaccine Sales Market Share by Application in 2016
Table EMEA Human Rotavirus Vaccine Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Human Rotavirus Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Human Rotavirus Vaccine by Region (2012-2017)
Figure EMEA Human Rotavirus Vaccine Sales Market Share in 2016
Table EMEA Human Rotavirus Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Human Rotavirus Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Human Rotavirus Vaccine by Region (2012-2017)
Figure EMEA Human Rotavirus Vaccine Revenue Market Share Regions in 2016
Table EMEA Human Rotavirus Vaccine Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Human Rotavirus Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Human Rotavirus Vaccine Sales (K MT) by Type (2012-2017)
Table Europe Human Rotavirus Vaccine Market Share by Type (2012-2017)
Figure Europe Human Rotavirus Vaccine Market Share by Type in 2016
Table Europe Human Rotavirus Vaccine Sales (K MT) by Application (2012-2017)
Table Europe Human Rotavirus Vaccine Market Share by Application (2012-2017)
Figure Europe Human Rotavirus Vaccine Market Share by Application in 2016
Table Europe Human Rotavirus Vaccine Sales (K MT) by Countries (2012-2017)
Table Europe Human Rotavirus Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Human Rotavirus Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Human Rotavirus Vaccine Sales Market Share by Countries in 2016
Table Europe Human Rotavirus Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Human Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Human Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Human Rotavirus Vaccine Revenue Market Share by Countries in 2016
Figure Germany Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure France Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure UK Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Human Rotavirus Vaccine Sales (K MT) by Type (2012-2017)
Table Middle East Human Rotavirus Vaccine Market Share by Type (2012-2017)
Figure Middle East Human Rotavirus Vaccine Market Share by Type (2012-2017)
Table Middle East Human Rotavirus Vaccine Sales (K MT) by Applications (2012-2017)
Table Middle East Human Rotavirus Vaccine Market Share by Applications (2012-2017)
Figure Middle East Human Rotavirus Vaccine Sales Market Share by Application in 2016
Table Middle East Human Rotavirus Vaccine Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Human Rotavirus Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Human Rotavirus Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Human Rotavirus Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Human Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Human Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Human Rotavirus Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Human Rotavirus Vaccine Sales (K MT) by Type (2012-2017)
Table Africa Human Rotavirus Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Human Rotavirus Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Human Rotavirus Vaccine Sales Market Share by Type in 2016
Table Africa Human Rotavirus Vaccine Sales (K MT) by Application (2012-2017)
Table Africa Human Rotavirus Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Human Rotavirus Vaccine Sales Market Share by Application (2012-2017)
Table Africa Human Rotavirus Vaccine Sales Volume (K MT) by Countries (2012-2017)
Table Africa Human Rotavirus Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Human Rotavirus Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Human Rotavirus Vaccine Sales Market Share by Countries in 2016
Table Africa Human Rotavirus Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Human Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Human Rotavirus Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Human Rotavirus Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Table Merck & Co., Inc. Human Rotavirus Vaccine Basic Information List
Table Merck & Co., Inc. Human Rotavirus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Merck & Co., Inc. Human Rotavirus Vaccine Sales Market Share in EMEA (2012-2017)
Figure Merck & Co., Inc. Human Rotavirus Vaccine Revenue Market Share in EMEA (2012-2017)
Table Bharat Biotech Human Rotavirus Vaccine Basic Information List
Table Bharat Biotech Human Rotavirus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bharat Biotech Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure Bharat Biotech Human Rotavirus Vaccine Sales Market Share in EMEA (2012-2017)
Figure Bharat Biotech Human Rotavirus Vaccine Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline plc. Human Rotavirus Vaccine Basic Information List
Table GlaxoSmithKline plc. Human Rotavirus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. Human Rotavirus Vaccine Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline plc. Human Rotavirus Vaccine Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Rotavirus Vaccine
Figure Manufacturing Process Analysis of Human Rotavirus Vaccine
Figure Human Rotavirus Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Human Rotavirus Vaccine Major Manufacturers in 2016
Table Major Buyers of Human Rotavirus Vaccine
Table Distributors/Traders List
Figure EMEA Human Rotavirus Vaccine Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Human Rotavirus Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Human Rotavirus Vaccine Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Human Rotavirus Vaccine Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Human Rotavirus Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Human Rotavirus Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Human Rotavirus Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Human Rotavirus Vaccine Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Human Rotavirus Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Human Rotavirus Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Human Rotavirus Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Human Rotavirus Vaccine Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Human Rotavirus Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Human Rotavirus Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Human Rotavirus Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Human Rotavirus Vaccine Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Human Rotavirus Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Human Rotavirus Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Human Rotavirus Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Human Rotavirus Vaccine Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Human Rotavirus Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Human Rotavirus Vaccine Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Human Rotavirus Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources